Grupo SURA

Colombiagruposura.com

Its role Investor / Financier

project tracked
1
partner companies
2
news article
1

Grupo SURA is a prominent Colombian financial holding company headquartered in Medellín. It oversees a portfolio of subsidiaries that provide insurance, pension fund management, asset management, and banking services throughout Latin America.

Read more

The company's main activities encompass life and non-life insurance, retirement savings plans, and investment management for both retail and institutional clients. It operates in multiple countries including Colombia, Chile, Mexico, and others, adapting its offerings to local market conditions.

Grupo SURA is publicly listed and features a group structure where the parent company holds controlling interests in its operating entities. This structure allows for diversified revenue streams and risk management across its financial operations.

In the industry, Grupo SURA ranks among the leading financial groups in Colombia and has established itself as a significant investor in various sectors, including healthcare and infrastructure projects. Its investments support economic growth and development in the regions where it operates.

With a history rooted in the Colombian economy, the group has evolved to become a diversified financial services provider. It emphasizes customer service, technological advancement in its operations, and compliance with regulatory standards in each market.

Grupo SURA's position is further enhanced by its strategic partnerships and its role in promoting financial inclusion and stability in emerging markets.

The project Grupo SURA is involved in

chemXplore tracks 1 project involving Grupo SURA, of which one is active.

VaxThera Rionegro Phase 2 Vaccine Facility Expansion
  1. Announced / Concept
  2. FEED / Pre-FID
  3. FID / Sanctioned
  4. Under Construction
  5. Commissioning & Start-up
Phase
Under Construction
Where
Colombia
Partners
EIB , VaxThera

Grupo SURA in chemical industry news

24 September 2026
EIB and European Commission back VaxThera vaccine facility in Colombia

€15m first tranche of a €35m package to expand a Colombian plant to produce up to 250m doses annually, plus a €1.5m R&D grant for three vaccine candidates.

Where its projects are

active all projects